TMT Newswire > PR Newswire
IFF Pharma Solutions Unveils Breakthrough Research at AAPS 2024 PharmSci 360

Attendees can explore the pivotal role of excipients in drug delivery and gain exclusive insights

NEW YORK, Oct. 14, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions will demonstrate the critical role of excipients in drug formulation by showcasing breakthrough research at AAPS 2024 PharmSci 360 in Salt Lake City, Utah, Oct. 20-23, at booth 2705. IFF Pharma Solutions' scientific posters and presentations will unveil key advancements in excipient selection targeting nitrosamine risk mitigation, controlled-release performance, extrusion spheronization processibility and pellet quality, softgel stability, and the formulation of plant-based pharmaceutical gummies.

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here